In collaboration with Payame Noor University and the Iranian Society of Instrumentation and Control Engineers

Document Type : Research Article

Authors

1 Faculty of Mathematics‎, ‎Shiraz University of Technology‎, ‎Shiraz‎, ‎Iran.

2 ABlauw-roodlaan 15‎, ‎2718 JN‎, Zoetermeer‎, ‎Netherlands.

3 Department of Mathematics‎, Jahrom University‎, ‎Iran‎.

10.30473/coam.2025.72347.1263

Abstract

Cancer is a class of diseases characterized by uncontrolled cell growth that affects immune cells‎. ‎There are several treatment options available‎, ‎including surgery‎, ‎chemotherapy‎, ‎hormonal therapy‎, ‎radiation therapy‎, ‎targeted therapy‎, ‎and palliative care‎. ‎Among these‎, ‎chemotherapy is one of the most widely used and recognized methods‎. ‎This paper‎ presents a novel model designed to control cancer cell growth based on a system of nonlinear fractional differential equations with delay in chemotherapy‎. ‎The model focuses on the competition between tumor and immune cells to minimize the number of tumor cells and determine the optimal dosage of the administered drug‎. ‎It can simulate various scenarios and predict the outcomes of different chemotherapy regimens‎. ‎By employing discretization and the Grunwald-Letnikov method‎, ‎we aim to gain insights into why some patients respond well to chemotherapy while others do not‎. ‎The results may also help identify potential drug targets and optimize existing treatments‎.

Highlights

  • Introduced a novel framework using nonlinear fractional differential equations for accurate simulation of cancer cell growth.
  • Developed a time-delay model to investigate the competitive dynamics between immune and tumor cells.
  • Achieved optimization of drug dosage personalized to individual patient responses, improving treatment outcomes.
  • Utilized the Grunwald-Letnikov method to effectively predict diverse patient responses to chemotherapy.

Keywords

Main Subjects

[1] Adimy, M., Crauste, F., and Ruan, S. (2005). “A mathematical study of the hematopoiesis process with applications to chronic myelogenous leukemia”, SIAM Journal on Applied Mathematics, 65(4), 1328-1352.
[2] Akman Yildiz, T., Arshad, S., and Baleanu, D. (2018). “Optimal chemotherapy and immunotherapy schedules for a cancer-obesity model with Caputo time fractional derivative”, Mathematical Methods in the Applied Sciences, 41(18), 9390-9407.
[3] Baleanu, D., Jajarmi, A., Sajjadi, S.S., and Mozyrska, D. (2019). “A new fractional model and optimal control of a tumor-immune surveillance with non-singular derivative operator”, Chaos: An Interdisciplinary Journal of Nonlinear Science, 29(8), 083127.
[4] Baleanu, D., Shekari, P., Torkzadeh, L., Ranjbar, H., Jajarmi, A., and Nouri, K. (2023). “Stability analysis and system properties of Nipah virus transmission: A fractional calculus case study”, Chaos, Solitons & Fractals, 166, 112990.
[5] Bozkurt, F. (2014). “Stability analysis of a fractional-order differential equation system of a GBM-IS interaction depending on the density”, Applied Mathematics & Information Sciences, 8 (3).
[6] Defterli, O., Baleanu, D., Jajarmi, A., Sajjadi, S.S., Alshaikh, N., and Asad, J.H. (2022). “Fractional treatment: An accelerated mass-spring system”, Romanian Reports in Physics, 74(4), 122.
[7] De Pillis, L.G., Radunskaya, A.E., and Wiseman, C.L. (2005). “A validated mathematical model of cell-mediated immune response to tumor growth”, Cancer Research, 65(17), 7950-7958.
[8] De Pillis, L.G., Gu, W., and Radunskaya, A.E. (2006). “Mixed immunotherapy and chemotherapy of tumors: Modeling, applications and biological interpretations”, Journal of Theoretical Biology, 238, 841-862.
[9] Hesameddini, E., and Azizi, M. (2016). “Grunwald-Letnikov scheme for system of chronic myelogenous leukemia fractional differential equations and its optimal control of drug treatment”, Journal of Mahani Mathematical Research Center, 5, 51-57.
[10] Hilfer, R., and Kleiner, T. (2020).“ Maximal domains for fractional derivatives and integrals”, Mathematics, 8(7), 1107.
[11] Fang, Wu. (2012). “Nabla fractional calculus and its application in analyzing tumor growth of cancer”, A Thesis Presented to the Faculty of the Department of Mathematics Western Kentucky University Bowling Green, Kentucky, December 2012.
[12] Fokas, A.S., Keller, J.B., and Clarkson, B.D. (1991). “Mathematical model of granulocytopoiesis and chronic myelogenous leukemia”, Cancer Research, 51, 2084-2091.
[13] Jumarie, G. (2006). “Modified Riemann-Liouville derivative and fractional Taylor series of non-differentiable functions further results”, Journal of Computers and Mathematics with Applications, 51, 1367-1376.
[14] Liu, W., and Freedman, H.I. (2005). “A mathematical model of vascular tumor treatment by chemotherapy”, Mathematical and Computer Modelling, 42, 1089-1112.
[15] Moore, H., and Li, N.K. (2004). “A mathematical model for chronic myelogenous leukemia (CML) and T cell interaction”, Journal of Theoretical Biology, 227 (4), 513-523.
[16] Namazi, H., Kulish, V.V., and Wong, A. (2015). “Mathematical modelling and prediction of the effect of chemotherapy on cancer cells”, Scientific Reports, 5(1), 13583.
[17] Podlubny, I. (1998). “Fractional differential equations: An introduction to fractional derivatives, fractional differential equations, to methods of their solution and some of their applications”, Elsevier.
[18] Pooseh, S., Almeida, R., and Torres, D.F. (2013). “A numerical scheme to solve fractional optimal control problems”, In Conference Papers in Science (Vol. 2013, No. 1, p. 165298). Hindawi Publishing Corporation.
[19] Pooseh, S., Almeida, R., and Torres, D.F.M. (2014). “Fractional order optimal control problems with free terminal time”, Journal of Industrial and Management Optimization, 10(2), 363-381.
[20] Rihan, F.A., Hashish, A., Al-Maskari, F., Hussein, M. S., Ahmed, E., Riaz, M.B., and Yafia, R. (2016). “Dynamics of tumor-immune system with fractional-order”, Journal of Tumor Research, 2(1), 109-115.